I
ImmunityBio, Inc.
IBRXHealth Care· Upland, California, US
LAYOFFS TRACKED
9
LAST EVENT
Jan 30, 2026
MARKET CAP
$8.74B
as of Aug 26, 2026
EMPLOYEES
50
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing biologic products to treat and prevent cancer and infectious diseases by harnessing and modulating the immune system. The company develops cytokine and T-cell activating therapies as well as vaccine candidates, with a pipeline including cancer immunotherapies and biologics for infectious disease prevention.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
50
25
11
3
1
1
Q4 '23Q1 '25Q1 '26Q3 '26
Layoff timeline
9 EVENTSNov 25, 2024WARN notice
Layoff at ImmunityBio, Inc. · ~15 roles
John Hopkins Court San Diego, CA · 5 locations
Oct 29, 2024WARN notice
Layoff at ImmunityBio, Inc. · ~10 roles
S Douglas Street El Segundo, CA · 4 locations
Stories from here
No one has shared a story from ImmunityBio yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for ImmunityBio
We'll email you the moment a new layoff is reported here.